Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Femasys Inc (FEMY)

Femasys Inc (FEMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,959
  • Shares Outstanding, K 22,898
  • Annual Sales, $ 1,070 K
  • Annual Income, $ -14,250 K
  • EBIT $ -17 M
  • EBITDA $ -17 M
  • 60-Month Beta -2.89
  • Price/Sales 23.28
  • Price/Cash Flow N/A
  • Price/Book 4.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -15.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9600 +13.54%
on 11/21/24
1.3000 -16.15%
on 12/10/24
+0.1130 (+11.57%)
since 11/20/24
3-Month
0.8600 +26.74%
on 11/19/24
1.4000 -22.14%
on 10/30/24
-0.0600 (-5.22%)
since 09/20/24
52-Week
0.7340 +48.50%
on 01/31/24
2.4000 -54.58%
on 03/04/24
+0.2070 (+23.44%)
since 12/20/23

Most Recent Stories

More News
Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed

FEMY : 1.0900 (-0.91%)
Femasys Inc. Publishes Positive Data from Pivotal FemaSeed® Trial in Journal of Gynecology & Reproductive Medicine

Femasys announces positive results for FemaSeed® intratubal insemination, demonstrating improved pregnancy rates in a pivotal clinical trial.Quiver AI SummaryFemasys Inc. announced the publication of...

FEMY : 1.0900 (-0.91%)
Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

FEMY : 1.0900 (-0.91%)
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update

FEMY : 1.0900 (-0.91%)
Femasys to Exhibit at the Annual AAGL 2024 Global Conference

FEMY : 1.0900 (-0.91%)
Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control

FEMY : 1.0900 (-0.91%)
Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed

FEMY : 1.0900 (-0.91%)
Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program

FEMY : 1.0900 (-0.91%)
Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

FEMY : 1.0900 (-0.91%)
5 of the Most Active Penny Stocks Worth Your Precious Time

These are five of the Most Active Penny Stocks in October that investors may find worthy of investment for 2024 and beyond

CHPT : 1.2400 (+8.77%)
SABR : 3.86 (+1.58%)
FEMY : 1.0900 (-0.91%)
NKLA : 1.1800 (+0.85%)
GRAB : 4.90 (-0.41%)

Business Summary

Femasys Inc.is a biomedical company focused on transforming women's healthcare by developing novel solutions as well as providing significant clinical impact to address severely underserved areas. The company's lead product candidates offer FemBloc and FemaSeed. Femasys Inc. is based in ATLANTA.

See More

Key Turning Points

3rd Resistance Point 1.1550
2nd Resistance Point 1.1400
1st Resistance Point 1.1150
Last Price 1.0900
1st Support Level 1.0750
2nd Support Level 1.0600
3rd Support Level 1.0350

See More

52-Week High 2.4000
Fibonacci 61.8% 1.7636
Fibonacci 50% 1.5670
Fibonacci 38.2% 1.3704
Last Price 1.0900
52-Week Low 0.7340

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar